What do systematic reviews say?

Summary of findings for AMBMT + PR vs PR

• Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 272 participants
  GRADE not reported

Summary of findings for AMBMT vs PR

• Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 74 participants
  Low

Summary of findings for AMBMT vs PR

• Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 11 participants
  Very low
• Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 139 participants
  Very low

Summary of findings for AMBMT vs PR

• Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 127 participants
  Very low

Summary of findings for AMBMT vs PR

• Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  8 studies · 490 participants
  GRADE not reported

Summary of findings for AMBMT + PR vs PR

• Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 80 participants
  Very low

Summary of findings for AMBMT + PR vs PR

• Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 80 participants
  Very low

Summary of findings for AMBMT + PR vs PR

• Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 192 participants
  Moderate

Once‐daily ICS/LABA combined inhalers vs once‐daily LAMA

It is very uncertain whether once‐daily ICS/LABA combined inhalers changes mortality (all‐cause) compared with once‐daily LAMA (very low certainty).

• Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic… 2018 · Cochrane Headline outcomes only
  OR 0.2 [0.02, 1.73]
  2 studies · 880 participants
  Very low

Once‐daily ICS/LABA combined inhalers vs once‐daily LAMA

It is very uncertain whether once‐daily ICS/LABA combined inhalers changes any COPD exacerbation that requires short‐burst oral corticosteroids… compared with once‐daily LAMA (very low certainty).

• Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic… 2018 · Cochrane Headline outcomes only
  OR 0.72 [0.35, 1.5]
  2 studies · 880 participants
  Very low

Once‐daily ICS/LABA combined inhalers vs once‐daily LAMA

It is very uncertain whether once‐daily ICS/LABA combined inhalers changes pneumonia compared with once‐daily LAMA (very low certainty).

• Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic… 2018 · Cochrane Headline outcomes only
  OR 6.12 [0.73, 51.24]
  2 studies · 880 participants
  Very low

Once‐daily ICS/LABA combined inhalers vs once‐daily LAMA

• Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 779 participants
  Very low

Once‐daily ICS/LABA combined inhalers vs once‐daily LAMA

It is very uncertain whether once‐daily ICS/LABA combined inhalers changes hospital admissions (all‐cause) compared with once‐daily LAMA (very low certainty).

• Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic… 2018 · Cochrane Headline outcomes only
  OR 0.96 [0.49, 1.89]
  2 studies · 880 participants
  Very low

Once‐daily ICS/LABA combined inhalers vs once‐daily LAMA

The review found no eligible studies for this question.

• Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Once‐daily ICS/LABA combined inhalers vs once‐daily LAMA

The review found no eligible studies for this question.

• Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Non‐invasive ventilation vs usual care

Non‐invasive ventilation probably leads to lower mortality compared with usual medical care (moderate certainty).

• Non‐invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic… 2017 · Cochrane Headline outcomes only
  RR 0.54 [0.38, 0.76]
  12 studies · 854 participants
  Moderate

Non‐invasive ventilation vs usual care

Non‐invasive ventilation probably leads to lower need for endotracheal intubation compared with usual medical care (moderate certainty).

• Non‐invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic… 2017 · Cochrane Headline outcomes only
  RR 0.36 [0.28, 0.46]
  17 studies · 1105 participants
  Moderate

Non‐invasive ventilation vs usual care

• Non‐invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic… 2017 · Cochrane Headline outcomes only
  no estimate extracted
  10 studies · 888 participants
  Moderate

Self‐management interventions vs usual care

• Self‐management interventions including action plans for exacerbations versus usual care in patients with chronic… 2017 · Cochrane Headline outcomes only
  no estimate extracted
  10 studies · 1582 participants
  High

Self‐management interventions vs usual care

• Self‐management interventions including action plans for exacerbations versus usual care in patients with chronic… 2017 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 217 participants
  Low